Testing effectiveness (Phase 2)Study completedNCT04540406
What this trial is testing
NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients
Who this might be right for
Suspected or Confirmed COVID-19
Notitia Biotechnologies Company 42